← Open Payments lookup

VICTOR SANCHEZ: Open Payments

NPI 1801440672 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,636 in 161 payments from 18 companies in 2025. Trend: 2023 $1,163 · 2024 $2,566 · 2025 $2,636

Food & beverage: $2,636
CompanyPaymentsAmount
ABBVIE INC.40$496
Madrigal Pharmaceuticals8$279
Salix Pharmaceuticals, a division of Bausch Health US, LLC15$241
Janssen Biotech, Inc.15$238
Takeda Pharmaceuticals U.S.A., Inc.11$213
Ipsen Biopharmaceuticals, Inc15$197
Gilead Sciences, Inc.11$175
Lilly USA, LLC10$165
GENZYME CORPORATION5$145
Phathom Pharmaceuticals, Inc.12$141

Products named: REZDIFFRA, TREMFYA, XIFAXAN, IQIRVO, RINVOQ, OMVOH, DUPIXENT, LINZESS.

Industry payments across TX — which companies pay providers there.